Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma

Journal of Nuclear Medicine

Volumn 46, Issue 6, 2005, Pages 978-982

  Koutsikos, John ^a,d   Athanasoulis, Theodores ^a   Anagnostopoulos, Athanasios ^b   Velidaki, Antigone ^c   Passadi, Marianthi ^a   Dimopoulos, Meletios Athanasios ^b   Zerva, Cherry ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Livadia Medical Center   (Greece)

^d NONE   (Greece)

Author keywords

99mTc MIBI; 99mTc V DMSA; Chemotherapy; Multiple myeloma; Treatment

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; MELPHALAN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SUCCIMER TC 99M; THALIDOMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BONE MARROW SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG UPTAKE; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; MIDDLE AGED; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TECHNETIUM TC 99M SESTAMIBI; TREATMENT OUTCOME;

EID: 23044443687     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Pace L, Catalano L, Del Vecchio S, et al. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up. Eur J Nucl Med. 2001;23:304-312.
2. Balleari E, Villa G, Garre S, et al. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease. Haematologica. 2001;86:78-84.
3. Pace L, Catalano L, Pinto A, et al. Different patterns of technetium-99m sestamibi uptake in multiple myeloma. Eur J Nucl Med. 1998;25:714-720.
4. 99mTc-MIBI scanning in multiple myeloma. Br J Cancer. 1996;74:1815-1820.
5. Ohta H, Endo K, Fujita T, et al. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent. Nucl Med Commun. 1988;9:105-116.
6. 99mTc-MIBI. Eur J Nucl Med. 2001;28:923-928.
7. Ohnishi T, Noguchi S, Murakami N, et al. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis. J Nucl Med. 1991;32:1785-1787.
8. Athanasoulis T, Koutsikos J, Moulopoulos LA, Tsiouris S, Dimopoulos MA, Zerva C. Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy. Clin Nucl Med. 2003;28:631-635.
9. Lee BF, Chen CJ, Yang CC, Yu HS. Psoas muscle abscess causing fever of unknown origin: the value of Tc-99m (V) DMS imaging. Clin Nucl Med. 1997;22:789-790.
10. Lee BF, Chiu NT, Chang JK, Liu GC, Yu HS. Technetium-99m(V)-DMSA and gallium-67 in the assessment of bone and joint infection. J Nucl Med. 1998;39:2128-2131.
11. 99mTc (V)DMSA scintigraphy in the detection and localization of intestinal inflammation: comparison of findings and colonoscopy and biopsy. Radiology. 2001;220:381-385.
12. 99mTc (V) DMSA scintigraphy. Radiology. 2003;229:70-74.
13. Catalano L, Pace L, Califano C, et al. Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy. Haematologica. 1999;84:119-124.
14. Denoyer D, Perek N, Le Jeune N, Frere D, Dubois F. The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic acid uptake. Cancer Biother Radiopharm. 2003;18:791-801.
15. Horiuchi K, Saji H, Yokoyama A. pH sensitive properties of Tc(V)-DMS: analytical and in vitro cellular studies. Nucl Med Biol. 1998;25:689-695.
16. Horiuchi K, Saji H, Yokoyama A. Tc(V)-DMS tumor localization mechanism: a pH-sensitive Tc(V)-DMS-enhanced target/nontarget ratio by glucose-mediated acidosis. Nucl Med Biol. 1998;25:549-555.
17. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000;27:822-832.
18. Drieskens O, Blockmans D, Van den Bruel A, Mortelmans L. Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings. Clin Nucl Med. 2002;27:413-415.
19. El-Shirbiny AM, Yeung H, Imbriaco M, Michaeli J, Macapinlac H, Larson SM. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma. J Nucl Med. 1997;38:1208-1210.